Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Neurosarcoidosis
1Formerly of the Centre for Neurosarcoidosis and WASOG Centre of Excellence, Neuroimmunology Unit, Institute of Immunity and Transplantation, Royal Free Hospital, London, NW3 2QG, England. desmond.kidd@nhs.net.
Abstract:
Sarcoidosis affects the nervous system in 5% of cases. 60% of cases involve the cranial and peripheral nerves, the remainder the central nervous system, in which a leptomeningitis, a pachymeningitis and a vasculitis may arise. Stroke and cerebral haemorrhage may occur, and certain infections in the brain are more likely with sarcoidosis. Patients respond well to treatment but oftentimes with residual neurological impairments which may be severe. A greater understanding of the disease and the need for early treatment and use of biological therapies have improved treatment outcome in recent times.
Related Concept Videos
Neural Regulation
Neurogenesis and Regeneration of Nervous Tissue

